Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI studyHauke Basedau, Arne May, Marlene Schellong et al.|eLife|2022Cited by 69
Author response: Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI studyHauke Basedau, Arne May, Lisa-Marie Sturm et al.|Unknown|2022Cited by 0